Spots Global Cancer Trial Database for anastrozole tablets
Every month we try and update this database with for anastrozole tablets cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study | NCT05645536 | Breast Cancer | TOL2506 Tamoxifen Letrozole table... Anastrozole Tab... Exemestane Tabl... | 18 Years - 51 Years | Tolmar Inc. | |
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer | NCT04906395 | Breast Cancer | TOL2506 Tamoxifen Letrozole Table... Anastrozole Tab... Exemestane Tabl... | 18 Years - 49 Years | Tolmar Inc. | |
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study | NCT05645536 | Breast Cancer | TOL2506 Tamoxifen Letrozole table... Anastrozole Tab... Exemestane Tabl... | 18 Years - 51 Years | Tolmar Inc. | |
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer | NCT04906395 | Breast Cancer | TOL2506 Tamoxifen Letrozole Table... Anastrozole Tab... Exemestane Tabl... | 18 Years - 49 Years | Tolmar Inc. |